1. Home
  2. TMP vs SPTX Comparison

TMP vs SPTX Comparison

Compare TMP & SPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tompkins Financial Corporation

TMP

Tompkins Financial Corporation

HOLD

Current Price

$100.99

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

N/A

Current Price

$23.78

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TMP
SPTX
Founded
1836
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
1996
2026

Fundamental Metrics

Financial Performance
Metric
TMP
SPTX
Price
$100.99
$23.78
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$87.00
N/A
AVG Volume (30 Days)
83.7K
93.2K
Earning Date
04-24-2026
N/A
Dividend Yield
3.21%
N/A
EPS Growth
126.16
N/A
EPS
3.86
N/A
Revenue
$75,742,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.94
N/A
P/E Ratio
$25.99
N/A
Revenue Growth
N/A
N/A
52 Week Low
$61.88
$17.59
52 Week High
$102.02
$24.65

Technical Indicators

Market Signals
Indicator
TMP
SPTX
Relative Strength Index (RSI) 61.77 66.31
Support Level $91.10 $18.72
Resistance Level $102.02 N/A
Average True Range (ATR) 2.27 1.34
MACD -0.17 0.25
Stochastic Oscillator 81.69 84.35

Price Performance

Historical Comparison
TMP
SPTX

About TMP Tompkins Financial Corporation

Tompkins Financial Corp is a Financial Holding Company. The company manages its operations through two business segments, consisting of banking and wealth management. It offers various products and services, including commercial and consumer banking, leasing, trust and investment management, financial planning and wealth management, and insurance. Wealth management activities include the results of the company's trust, financial planning, and wealth management services. The company generates the majority of its revenue from the Banking segment.

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

Share on Social Networks: